Private Equity 3 Hours

Last updated: May 21, 2026, 2:30 AM ET

Quantum & AI Deal Flow

European quantum firms gain a competitive edge as U.S. giants prepare to acquire overseas talent, a trend that could reshape the sector’s geography lead in quantum race. Amidst this, the UK‑France‑Germany DARPA‑style partnership aims to cement Europe’s AI leadership, offering a structured funding pathway for startups that could counter U.S. dominance UK‑France‑Germany alliance. The move aligns with Anthropic’s stance that vertical AI companies will not be displaced by larger incumbents, a view echoed by Lexroom’s CEO who cautions that niche AI solutions retain market relevance Anthropic stance.

Founder‑Driven Advisory Models

A serial entrepreneur who struggled to find a financial adviser has instead built her own advisory framework, a strategy that could inspire other founders to take control of capital deployment and reduce reliance on traditional VC intermediaries founder builds own adviser.

Biotech‑Quantum Synergy

Imperagen, a biotech startup leveraging quantum physics and AI for enzyme engineering, secured a £5 million ($6.7 seed round led by PXN Ventures, with IQ Capital and Northern Gritstone joining the table. The infusion targets accelerated research into next‑generation biocatalysts, positioning the company at the intersection of quantum computing and precision biology Imperagen raises £5m.